Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes: the first approved & fda max : 20 mg/d or 80 mg/d

Use the filters below to narrow your results.

generic:
None (1)
brand:
Belsomra (1)
classes: (Click arrow to add another value)
mechanism:
Competitive antagonist at OX1R and OX2R. First-in-class DORA. Receptor dissociation slower than lemborexant or daridorexant. (1)
uses:
Insomnia (sleep onset and/or maintenance) in adults (FDA-approved August 2014). Also studied for insomnia in mild-moderate Alzheimer disease. (1)
starting dose:
10 mg PO 30 min before bedtime (with ≥7 hours of sleep planned) (1)
preparations:
5 mg, 10 mg, 15 mg, 20 mg tablets (1)
fda max: (Click arrow to add another value)
routes:
Oral (1)
onset:
~30 min (1)
duration:
~7-8 hours (1)
halflife:
~12 hours (1)
bioavailability:
~82% (1)
pregnancy:
Limited data; avoid (1)
legal:
Rx, Schedule IV (US) (1)

Showing below up to 1 result in range #1 to #1.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"